Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO/WCM 2025 | Adjuvant/neoadjuvant treatment of cutaneous SCC

Vishal Patel • 3 Apr 2025
EADO/WCM 2025
Cutaneous Squamous Cell Carcinoma Skin Cancer

Vishal Patel, MD, FAAD, FACMS, George Washington University (GW), Washington, DC, comments on the shifting paradigm in treating locally advanced cutaneous squamous cell carcinoma (SCC), highlighting the evolution from surgical therapy to immunotherapy, with impressive results from pivotal trials and promising data on adjuvant immunotherapy, leading to significantly improved outcomes. This interview took place at the 11th World Congress of Melanoma and 21st EADO Congress in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vishal Patel

Neoadjuvant approaches for cutaneous SCC
1:58
Neoadjuvant approaches for cutaneous SCC
Vishal Patel • 3 Apr 2025
Systemic immunotherapy for locally advanced cutaneous squamous carcinoma
1:27
Systemic immunotherapy for locally advanced cutaneous squamous carcinoma
Vishal Patel • 3 Apr 2025
Promise of adjuvant immunotherapy in cutaneous SCC
1:05
Promise of adjuvant immunotherapy in cutaneous SCC
Vishal Patel • 3 Apr 2025
Key unmet needs of high-risk squamous cell carcinoma
1:35
Key unmet needs of high-risk squamous cell carcinoma
Vishal Patel • 26 Nov 2022

Related Videos

BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
1:45
BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
Kalijn Bol • 31 May 2026
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
1:08
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
Kalijn Bol • 31 May 2026
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
1:02
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
Kalijn Bol • 31 May 2026
The future of personalized and off-the-shelf mRNA vaccines in melanoma
1:02
The future of personalized and off-the-shelf mRNA vaccines in melanoma
James Smithy • 31 May 2026
The content of VJOncology is intended for healthcare professionals